JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹11 Cr | ₹6.09 Cr | ₹7.96 Cr | ₹8.08 Cr | ₹6.06 Cr |
What is the latest Contingent Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹6.09 Cr |
Mar2022 | ₹7.96 Cr |
Mar2021 | ₹8.08 Cr |
Mar2020 | ₹6.06 Cr |
How is Contingent Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | 84.29 | |
Mar2023 | ₹6.09 Cr | -23.57 | |
Mar2022 | ₹7.96 Cr | -1.44 | |
Mar2021 | ₹8.08 Cr | 33.42 | |
Mar2020 | ₹6.06 Cr | - |
Compare Contingent Liabilities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,719.2 Cr | 5.3% | -11.5% | 56.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹453,426.0 Cr | 2.6% | 4.5% | 49.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,165.0 Cr | 3.2% | -2.9% | 54.9% | Stock Analytics | |
CIPLA | ₹123,634.0 Cr | 2.8% | 1.5% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,274.0 Cr | 1.1% | 12.1% | 18.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,972.0 Cr | 1.5% | -0.1% | 41.6% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 5.3% |
-11.5% |
56.8% |
SENSEX | 0% |
-1.6% |
9% |
You may also like the below Video Courses